|
1
|
Walters JG and Garrity PF: RDW-SD and
RDW-CV: Their relationship to RBC distribution curves and
anisocytosis. Sysmex J Int. 3:40–45. 1993.
|
|
2
|
Sultana GS, Haque SA, Sultana T and Ahmed
AN: Value of red cell distribution width (RDW) and RBC indices in
the detection of iron deficiency anemia. Mymensingh Med J.
22:370–376. 2013.PubMed/NCBI
|
|
3
|
Felker GM, Allen LA, Pocock SJ, Shaw LK,
McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL,
et al: Red cell distribution width as a novel prognostic marker in
heart failure: Data from the charm program and the duke databank. J
Am Coll Cardiol. 50:40–47. 2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jo YH, Kim K, Lee JH, Kang C, Kim T, Park
HM, Kang KW, Kim J and Rhee JE: Red cell distribution width is a
prognostic factor in severe sepsis and septic shock. Am J Emerg
Med. 31:545–548. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ozsu S, Ozcelik N, Oztuna F and Ozlu T:
Prognostic value of red cell distribution width in patients with
sarcoidosis. Clin Respir J. 9:34–38. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bilgin B, Sendur MA, Hizal M, Dede DS,
Akinci MB, Kandil SU, Yaman S, Yalçin A, Kiliç M and Yalçin B:
Prognostic effect of red cell distribution width-to-platelet ratio
in colorectal cancer according to tumor stage and localization. J
Cancer Res Ther. 15:54–60. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Huang DP, Ma RM and Xiang YQ: Utility of
red cell distribution width as a prognostic factor in young breast
cancer patients. Medicine (Baltimore). 95(e3430)2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wan GX, Chen P, Cai XJ, Li LJ, Yu XJ, Pan
DF, Wang XH, Wang XB and Cao FJ: Elevated red cell distribution
width contributes to a poor prognosis in patients with esophageal
carcinoma. Clin Chim Acta. 452:199–203. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Winckelmans T, Decaluwé H, De Leyn P and
Van Raemdonck D: Segmentectomy or lobectomy for early-stage
non-small-cell lung cancer: A systematic review and meta-analysis.
Eur J Cardiothorac Surg. 57:1051–1060. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ijsseldijk MA, Shoni M, Siegert C, Seegers
J, van Engelenburg AK, Tsai TC, Lebenthal A and Ten Broek RP:
Oncological outcomes of lobar resection, segmentectomy, and wedge
resection for T1a non-small-cell lung carcinoma: A systematic
review and meta-analysis. Semin Thorac Cardiovasc Surg. 32:582–590.
2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Brierley JD, Gospodarowicz MK and
Wittekind CH (eds): TNM classification of malignant tumours. 8th
edition. John Wiley & Sons, Chichester, West Sussex, pp106-112,
2017.
|
|
12
|
Travis WD, Brambilla E, Muller-Hermelink
HK and Harris CC: Pathology and genetics of tumours of the lung,
pleura, thymus and heart. In: World Health Organization
Classification of Tumours. Kleihues P and Sobin LH (eds). Lyon,
International Agency for Research on Cancer Press, pp9-124,
2004.
|
|
13
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR' for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Förhécz Z, Gombos T, Borgulya G, Pozsonyi
Z, Prohászka Z and Jánoskuti L: Red cell distribution width in
heart failure: Prediction of clinical events and relationship with
markers of ineffective erythropoiesis, inflammation, renal
function, and nutritional state. Am Heart J. 158:659–666.
2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Toyokawa G, Shoji F, Yamazaki K, Shimokawa
M and Takeo S: Significance of the red blood cell distribution
width in resected pathologic stage I nonsmall cell lung cancer.
Semin Thorac Cardiovasc Surg. 32:1036–1045. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bozkaya Y, Kurt B and Gürler F: A
prognostic parameter in advanced non-small cell lung cancer: The
ratio of hemoglobin-to-red cell distribution width. Int J Clin
Oncol. 24:798–806. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kiriu T, Yamamoto M, Nagano T, Koyama K,
Katsurada M, Tamura D, Nakata K, Tachihara M, Kobayashi K and
Nishimura Y: Prognostic value of red blood cell distribution width
in non-small cell lung cancer treated with anti-programmed cell
death-1 antibody. In Vivo. 33:213–220. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kobayashi S, Karube Y, Inoue T, Araki O,
Maeda S, Matsumura Y and Chida M: Advanced lung cancer inflammation
index predicts outcomes of patients with pathological stage IA lung
adenocarcinoma following surgical resection. Ann Thorac Cardiovasc
Surg. 25:87–94. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ichinose J, Murakawa T, Kawashima M,
Nagayama K, Nitadori JI, Anraku M and Nakajima J: Prognostic
significance of red cell distribution width in elderly patients
undergoing resection for non-small cell lung cancer. J Thorac Dis.
8:3658–3666. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kos M, Hocazade C, Kos FT, Uncu D, Karakas
E, Dogan M, Uncu HG, Ozdemir N and Zengin N: Evaluation of the
effects of red blood cell distribution width on survival in lung
cancer patients. Contemp Oncol (Pozn). 20:153–157. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Koma Y, Onishi A, Matsuoka H, Oda N,
Yokota N, Matsumoto Y, Koyama M, Okada N, Nakashima N, Masuya D, et
al: Increased red blood cell distribution width associates with
cancer stage and prognosis in patients with lung cancer. PLoS One.
8(e80240)2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Warwick R, Mediratta N, Shackcloth M, Shaw
M, McShane J and Poullis M: Preoperative red cell distribution
width in patients undergoing pulmonary resections for
non-small-cell lung cancer. Eur J Cardio Thorac Surg. 45:108–113.
2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Goldstraw P, Chansky K, Crowley J,
Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P,
Mitchell A, Bolejack V, et al: The IASLC lung cancer staging
project: Proposals for revision of the TNM stage groupings in the
forthcoming (eighth) edition of the TNM classification for lung
cancer. J Thorac Oncol. 11:39–51. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Fearon K, Strasser F, Anker SD, Bosaeus I,
Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N,
Mantovani G, et al: Definition and classification of cancer
cachexia: An international consensus. Lancet Oncol. 12:489–495.
2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tisdale MJ: Cachexia in cancer patients.
Nat Rev Cancer. 2:862–871. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie
Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA,
et al: Sarcopenia: Revised European consensus on definition and
diagnosis. Age Ageing. 48(601)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Fearon KC, Glass DJ and Guttridge DC:
Cancer cachexia: Mediators, signaling, and metabolic pathways. Cell
Metab. 16:153–166. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Argilés JM, Busquets S, Stemmler B and
López-Soriano FJ: Cancer cachexia: Understanding the molecular
basis. Nat Rev Cancer. 14:754–762. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Op den Kamp CM, Langen RC, Minnaard R,
Kelders MC, Snepvangers FJ, Hesselink MK, Dingemans AC and Schols
AM: Pre-cachexia in patients with stages I-III non-small cell lung
cancer: Systemic inflammation and functional impairment without
activation of skeletal muscle ubiquitin proteasome system. Lung
Cancer. 76:112–117. 2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Deutz NE, Safar A, Schutzler S, Memelink
R, Ferrando A, Spencer H, van Helvoort A and Wolfe RR: Muscle
protein synthesis in cancer patients can be stimulated with a
specially formulated medical food. Clin Nutr. 30:759–768.
2011.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Templeton AJ, McNamara MG, Šeruga B,
Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G,
Knox JJ, Tran B, et al: Prognostic role of neutrophil-to-lymphocyte
ratio in solid tumors: A systematic review and meta-analysis. J
Natl Cancer Inst. 106(dju124)2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Łochowski M, Łochowska B, Zawadzka I,
Cieślik-Wolski B, Kozik D and Kozak J: Prognostic value of
neutrophil-to-lymphocyte, platelet-to-lymphocyte and
lymphocyte-to-monocyte ratio ratios in patients operated on due to
non-small cell lung cancer. J Thorac Dis. 11:3377–3384.
2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Forrest LM, McMillan DC, McArdle CS,
Angerson WJ and Dunlop DJ: Evaluation of cumulative prognostic
scores based on the systemic inflammatory response in patients with
inoperable non-small-cell lung cancer. Br J Cancer. 89:1028–1030.
2003.PubMed/NCBI View Article : Google Scholar
|
|
34
|
McMillan DC: Systemic inflammation,
nutritional status and survival in patients with cancer. Curr Opin
Clin Nutr Metab Care. 12:223–226. 2009.PubMed/NCBI View Article : Google Scholar
|
